Evidence map›Paper›PMID 32659980›Full record

ArticleBiomolecules2020

Julia Hohenbichler, Georg Aichinger, Michael Rychlik, Giorgia Del Favero, Doris Marko

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Chemical research in toxicology · 2022
    Article
  8. Review
  9. Allergy to Fungi in Veterinary Medicine:Journal of fungi (Basel, Switzerland) · 2022
    Review
  10. Secondary metabolites ofFrontiers in microbiology · 2022
    Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Julia HohenbichlerDepartment of Food Chemistry and Toxicology, University of Vienna, 1090 Vienna, Italy.ORCID 0000-0002-9134-2254
Georg AichingerDepartment of Food Chemistry and Toxicology, University of Vienna, 1090 Vienna, Italy.ORCID 0000-0003-1691-7609
Michael RychlikChair of Analytical Chemistry, Technical University of Munich, 80333 Munich, Germany.ORCID 0000-0002-5826-6288
Giorgia Del FaveroDepartment of Food Chemistry and Toxicology, University of Vienna, 1090 Vienna, Italy.ORCID 0000-0001-8633-5458
Doris MarkoDepartment of Food Chemistry and Toxicology, University of Vienna, 1090 Vienna, Italy.ORCID 0000-0001-6568-2944
Technical University of Munich · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AlternariaAryl Hydrocarbon HydroxylasesBasic Helix-Loop-Helix ProteinsBenz(a)AnthracenesBreast NeoplasmsCell ProliferationCell SurvivalDrug SynergismFemaleGene Expression Regulation, NeoplasticHumansLactonesMCF-7 CellsMycotoxinsPeryleneReceptors, Aryl HydrocarbonAHR protein, humanalternariolalternariol monomethyl etheraltertoxin Ialtertoxin IIAryl Hydrocarbon HydroxylasesBasic Helix-Loop-Helix ProteinsBenz(a)AnthracenesLactonesMycotoxinsPeryleneReceptors, Aryl Hydrocarboncombinatory effectsemerging mycotoxinsphase I metabolismsynergism

Identifiers

PMID32659980
PMCPMC7407958
OpenAlexW3040740917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.